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INTRODUCTION
Drug-induced photosensitivity can be elicited by topical or systemic application of pharmaceutical substances in combination with subsequent exposure to sunlight or artificial light (Drucker and Rosen, 2011; Moore, 2002) . As the photochemical reactions of drug molecules are a key trigger of phototoxic reactions, photochemical evaluations such as ultraviolet (UV) spectral analysis and reactive oxygen species (ROS) assay are carried out as photosafety assessments in pharmaceutical research to avoid adverse phototoxic events (Onoue et al., 2009; Seto et al., 2012) . In addition to photochemical evaluation, pharmacokinetic (PK) evaluation with a focus on sunlight-exposed tissues (e.g. skin and eyes) can also be helpful for predicting in vivo phototoxicity, as phototoxic reactions mainly occur in the skin (Seto et al., 2009; Seto et al., 2011) . Currently, regulatory agencies recommend PK characterization as well as photochemical characterization for the photosafety assessment on pharmaceuticals.
For example, tissue distribution is recommended in the guidelines for photosafety assessment of pharmaceuticals published by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (ICH, 2013) .
In many cases of drug-induced photosensitivity, phototoxic reactions are thought of as mainly being elicited by parent drugs, and the photosafety of drug metabolites is, in principle, outside the scope of regulatory oversight (ICH, 2013) . However, the metabolites of phototoxic compounds can have phototoxicity that is as potent as that of their parent drugs, and some metabolites have even more potent phototoxic potential than their parent chemicals, including amiodarone, chlorpromazine, and fenofibrate, (Ferguson This article has not been copyedited and formatted. The final version may differ from this version. et al., 1985; Ljunggren and Moller, 1977; Ljunggren, 1977; Miranda et al., 1994) . In our previous investigation, in vivo phototoxic risk of chlorpromazine was predicted to be less phototoxic on the basis of the photochemical and PK characteristics of its parent compounds although, in fact, potent in vivo phototoxic reaction was observed in the rat skin after oral administration of chlorpromazine (Onoue et al., 2014) . Chlorpromazine taken orally has been found to be extensively metabolized by cytochrome P450 (Wojcikowski et al., 2010) , and its demethylated metabolites have been found to be more phototoxic than chlorpromazine (Ljunggren and Moller, 1977) . In this context, false predictions might arise from the lack of photochemical and PK characterization on metabolites, and the photosafety assessments of metabolites as well as their parent chemicals should provide more reliable photosafety information on pharmaceuticals;
however, the feasibility of such new screening strategies is unknown.
The present study aimed to establish a new photosafety assessment strategy with the combined use of photochemical and PK characterization on a parent drug and its metabolites, applying this new screening strategy to fenofibrate (FF) and its major metabolites, fenofibric acid (FA) and reduced fenofibric acid (RFA) (Fig. 1) . FF, an anti-hyperlipoproteinemic agent, is clinically recognized as phototoxic (Leenutaphong and Manuskiatti, 1996; Machet et al., 1997; Roberts, 1989) , and the phototoxic potential of FF has been investigated using several in vitro tools, demonstrating the potent in vitro phototoxicity of FF and FA (Miranda et al., 1994; Vargas et al., 1993) . Thus, in the present study, FF and its metabolites were employed as model chemicals to confirm the feasibility of the new screening strategy. The photoreactivity of these compounds was
Irradiation conditions for determination of ROS
An Atlas Suntest CPS plus (Atlas Material Technology LLC, Chicago, IL, USA) equipped with a xenon arc lamp (1,500 W) and a cooling unit SR-P20FLE (Hitachi, Tokyo, Japan) was used for determination of ROS from irradiated chemicals. A UV special filter was installed to adapt the spectrum of the artificial light source to that of natural daylight;
the Atlas Suntest CPS series has a high irradiance capability that meets CIE85/1989 daylight simulation requirements. The irradiation test was carried out at 25°C with an irradiance of ca. 2.0 mW/cm 2 as determined with a calibrated UVA detector Dr.
Hönle#0037 (Dr. Hönle, München, Germany).
Determination of ROS from photo-irradiated compounds
Determination of singlet oxygen and superoxide generated from photo-irradiated compounds was conducted in accordance with established protocol (Seto et al., 2013a ).
Briefly, each tested compound was dissolved in dimethyl sulfoxide (DMSO) at 10 mM for stock solution. To monitor the generation of singlet oxygen, samples containing compounds (200 μM), p-nitrosodimethylaniline (50 µM) and imidazole (50 µM) in 20 mM NaPB (pH7.4) with 0.5% (v/v) Tween 20 were irradiated with simulated sunlight, and then the UV absorption at 440 nm was measured using SAFIRE (TECAN, Männedorf, Switzerland) . For the determination of superoxide generation, samples containing the compounds (200 μM) and NBT (50 µM) in 20 mM NaPB (pH7.4) with 0.5% (v/v) Tween 20 were exposed to simulated sunlight, and the reduction of NBT was measured by the increase in the absorbance at 560 nm using SAFIRE. According to the results (mean of This article has not been copyedited and formatted. The final version may differ from this version. 
Determination of ROS from photo-irradiated compounds in enzyme-treated samples
Rat hepatic/intestinal S9 fractions were pre-incubated for 2 min at 37°C (final concentration: 0.2 mg-protein/mL) in 0.3 mL of phosphate buffer (pH7.4) containing typical co-factors. FF was dissolved in DMSO at 10 mM as a stock solution. The reaction was initiated by the addition of FF at 100 μM, and the final concentration of DMSO was 1%. The reaction was terminated at 1 min by adding 0.2 mL of ice-cold ethanol. For comparison, FF (100 μM) was also incubated with heat-inactivated (ca. 80°C, 5 min) S9 fractions (denatured groups). The mixtures were evaluated by ROS assay (Onoue et al., 2013a) . Briefly, to monitor the generation of singlet oxygen, enzyme-treated mixture, p-nitrosodimethylaniline (50 µM) and imidazole (50 µM) were dissolved in 20 mM NaPB (pH7.4). For the determination of superoxide generation, enzyme-treated mixture and NBT (50 µM) were dissolved in 20 mM NaPB (pH7.4). Both reaction mixtures theoretically contained 50 μM of FF. Then, these samples were This article has not been copyedited and formatted. The final version may differ from this version. 
PK study
Blood samples were taken in a volume of 200 μL from the tail vein in the indicated periods (0.5, 1, 2, 3, 4, 6, 8, 12, 24 , and 48 h) after drug administration. The blood samples were centrifuged (10,000×g, 10 min, 4°C) to prepare plasma samples, and then the samples (100 μL) were deproteinized by addition of acetonitrile (250 μL). The supernatants were obtained by centrifugation (2,000 rpm, 1 min, 4°C) and filtration (0.20 μm membrane filter; Millex ® -LG， Millipore, Billerica, MA, USA) and kept frozen at -20°C until they were analyzed.
At the indicated times (2, 4, 6, 8, 10, 12, 24 , and 48 h) after oral administration of FF, rats were humanely killed by taking blood from the descending aorta under anesthesia with pentobarbital Na (50 mg/kg), and the tissues were then perfused with cold saline from the aorta. The skin and eye were dissected, minced with scissors, and homogenized using Physcotron (Microtec, Chiba, Japan) in 4 mL of acetonitrile. After sonication for 10 min and shaking for 10 min, the samples were centrifuged (3,000 rpm, 10 min). Extraction was repeated twice with acetonitrile, and the supernatants were pooled. The collected eluents were pooled with acetonitrile extracts, and the samples were evaporated to dryness under a gentle stream of nitrogen at 45°C. The extracted and evaporated tissue samples were stored at 4°C until they were analyzed.
The ultra-performance liquid chromatography equipped with electrospray ionization mass spectrometry (UPLC/ESI-MS) system was employed for the determination of the drug concentration in plasma and tissue samples (Onoue et al., 2013b 
3T3 NRU PT
The Balb/c 3T3 mouse fibroblast cells (CloneA-31) were maintained in culture as previously reported (Spielmann et al., 1991) . The 3T3 neutral red uptake phototoxicity test (3T3 NRU PT) and data analyses were carried out as described in the Organization for 
In vivo phototoxicity test
Experiments were performed as described previously with minor changes in dermal administration (Seto et al., 2009) . Each FF, FA, or control (quinine and sulisobenzone) was dissolved in DMSO at 100 mg/mL, and was applied to 2 application sites on rat skin at the abdomen (10 mg/site, n=4) using filter paper (2 cm×2 cm) under anesthesia with pentobarbital Na (50 mg/kg). At 4 h after dermal administration, the filter papers containing chemicals on the application sites were removed and wiped using cotton soaked with distilled water. Then, rats were irradiated individually using black light (FL15BL-B, National, Tokyo, Japan) as a UVA light source with an irradiance of ca. 2.7 mW/cm 2 for ca. 3 h until the UV irradiance level reached 30 J/cm 2 . Because UVB light is highly cytotoxic, a UVA light source was employed for the in vivo phototoxicity testing.
During the UVA irradiation, rats were restrained on a sunbed under anesthesia with pentobarbital Na (50 mg/kg) to ensure uniform irradiation of their abdomen, and non-irradiated sites were wrapped in aluminum foil for protection from UV light. UV intensity was monitored using the calibrated UVA detector Dr. Hönle no. 0037 (Dr. Hönle).
A colorimeter equipped with a data processor (NF333, Nippon Denshoku, Tokyo, Japan)
This article has not been copyedited and formatted. The final version may differ from this version. axis represents the balance between yellow (positive values up to 100) and blue (negative values up to −100). The differences in skin color (ΔE) between before and after irradiation were described as follows (Pierard and Pierard-Franchimont, 1993; Westerhof et al., 1986) :
Data analysis
The significance of differences was determined by Student's t-test on the data from ROS generation after incubation with rat hepatic/intestinal S9 fractions. Other data were analyzed by one-way analysis of variance followed by Tukey's multiple comparison tests. 
RESULTS
Photochemical characterization
Phototoxic reactions can be triggered by photochemical reactions of drug molecules following absorption of UV and visible light (VIS) (290-700 nm) (Moore, 1998; Onoue and Tsuda, 2006 classification system, and the photoreactivity of the compounds was ranked as follows: FA ＞ FF≫RFA.
ROS generation from enzyme-treated FF was determined after incubation with rat hepatic/intestinal S9 fractions to evaluate the possible photochemical transitions of FF after metabolism (Fig. 2C) . Although no significant differences were observed in ROS generation from FF between pre-treatment of active and denatured rat intestinal S9
fractions, the generation of superoxide from FF was significantly increased by ca. 4.5-fold after pre-incubation with active rat hepatic S9 fractions compared with that from FF incubated with the denatured one (P＜0.05), suggesting enhanced photoreactivity of FF after metabolism in liver.
PK characterization
Phototoxic reactions mainly occur in skin and eyes; thus, dermal and ocular exposure to compounds can be a predictive factor for in vivo phototoxicity as well as systemic exposure (Boiy et al., 2008; Seto et al., 2009) . PK characterizations of compounds were conducted with a focus on plasma, skin and eyes ( Fig. 3 and Table 1 ).
After oral administration of FF to rats, FF was negligible in all tissues (below the limit of detection: 10 ng/mL and 7.1 ng/g tissue), and on the other hand, its metabolites could be detected in plasma and tissues. Rapid and sustained increase of FA level was observed in all tissues up to 6.0-13 h, whereas RFA concentrations in plasma and skin were gradually On the other hand, RFA exhibited slower elimination from plasma and skin compared with FA, as evidenced by the ca. 1.5-to 2-fold-longer apparent half-lives of RFA compared with FA in plasma and skin, suggesting longer tissue retention of RFA. From the PK characteristics, dermal and ocular exposure was ranked as follows: FA＞RFA≫FF.
Comparative in vitro/in vivo photosafety assessments
When both photochemical and PK data are taken into account, FA was more likely to be phototoxic than the others; then, the photosafety of FA was examined by both 3T3
NRU PT, a well-validated alternative method for photosafety assessment (Spielmann et al., 1998) , and rat in vivo phototoxicity test, and FF was also tested for comparison. Quinine (QN) and sulisobenzone (SB) were employed as positive/negative controls in both in vitro/in vivo photosafety tests, respectively. In 3T3 NRU PT, cell viability curves were almost identical between UV-irradiated and non-irradiated groups treated with SB (Fig. 4A ).
In contrast, QN induced potent phototoxicity to 3T3 cells after UV irradiation. As observed for QN, FF and FA also exhibited enhanced cell death upon UV exposure, indicating potent phototoxicity to 3T3 cells (Fig. 4B) In vivo photosafety profiles were assessed based on the transitions in skin color (ΔE) after UV irradiation following dermal administration of FF, FA, QN, and SB (Fig. 4C ).
Dermal concentrations of FF and FA did not increase from 2 to 6 h after dermal application (data not shown), suggesting steady-state concentrations of the drugs in skin; then, the application period was confirmed at 4 h in the present study. In SB-treated groups, no significant differences were observed between UV-irradiated and non-irradiated rats. On the other hand, upon UV irradiation, QN induced significant increase of the ΔE value owing to the increase of the Δb* value, as previously observed (Nose and Tsurumi, 1993).
UV-irradiated FF and FA also exhibited significantly higher ΔE values than each non-irradiated group (P＜0.05), and these color changes were due to significant increases of Δb* values by 6.4 (for FF) and 5.9 (for FA). Furthermore, in FA-treated groups, the Δa* value was also significantly increased by 4.7 upon UV irradiation. Although ΔE values were not significantly different between UV-irradiated FF and UV-irradiated SB, the ΔE value of UV-exposed rats treated with FA was significantly higher than that of UV-exposed rats treated with SB (P＜0.05). These results demonstrated more severe phototoxicity of FA than FF to rat skin.
This article has not been copyedited and formatted. The final version may differ from this version. in UV-irradiated groups, the metabolic activity for conversion of FF to FA might not be high in 3T3 cells and rat skin; phototoxicity of FA would be more potent than that of FF on the basis of the data obtained.
In photosafety assessment, both photochemical and PK properties should be taken into consideration; thus, a summary table was built upon photochemical and PK data (Table   2) , and values among the data are classified as high, moderate and low levels in accordance with our previous research (Seto et al., 2011) . In the present photosafety prediction, high levels for both photochemical and PK data might indicate high phototoxic potential, whereas, low levels in either or both might be indicative of moderate or low phototoxic potential. FA was deduced to be a highly phototoxic metabolite because both photoreactivity and dermal/ocular exposure were high. FF and RFA were less phototoxic owing to limited dermal/ocular exposure of FF, moderate photoreactivity and limited ocular This article has not been copyedited and formatted. The final version may differ from this version. Leenutaphong and Manuskiatti, 1996) .
Many drugs seemed to exhibit different PK behavior between humans and non-human primates, which may partly be due to species differences of metabolic enzymes, such as CYPs, esterases and glucuronidases (Baillie and Rettie, 2011) . FF is metabolized into FA by CES 1A1 in the liver after absorption, and a portion of it undergoes carbonyl reduction by CYP 3A4 to produce RFA, and then these metabolites and their glucuronides are excreted (Cornu-Chagnon et al., 1995; Fukami et al., 2010; Miller and Spence, 1998; Weil et al., 1988; 1990) . Thus, outcomes from PK assessment could not be completely extrapolated to humans as long as inter-species differences existed in the enzymes related to FF metabolism. According to a previous report, no significant differences were reported between human and rat hepatic CES 1A1 activity, and furthermore, plasma PK behavior of FA in humans was in agreement with PK data in rats obtained in the present study (Lovin et al., 2003; Taketani et al., 2007) . Thus, FA might also exhibit high dermal exposure in humans as observed in rats. On the other hand, in humans, there appeared to be inter-individual variability in PK, efficacy and safety profiles of orally administered FF This article has not been copyedited and formatted. The final version may differ from this version. hence, the effect of food intake, especially high-fat meals, might have a major impact on the photosafety of oral FF therapy since dermal exposure of FA might be increased when FF is orally taken with high-fat meals.
To avoid undesired phototoxic events, early identification of a hazard for metabolite-mediated phototoxicity would be of great help in drug discovery. In general, to evaluate a hazard for metabolite-related toxicity without identification of metabolites, several methods have been developed based on a combination strategy of general toxicity tests and in vitro metabolism studies (Ames et al., 1973; Geissler and Faustman, 1988) .
As for phototoxicity, the phototoxic hazard of metabolites might be evaluated based on transitions of ROS generation from light-irradiated compounds after treatment with metabolizing enzymes, as observed in the present study; however, singlet oxygen generation from some irradiated samples was negligible in the ROS assay with S9 fractions, whereas potent singlet oxygen generation from irradiated FF and FA was observed in the mROS assay. Changes of photochemical reactions in the ROS assay were attributed to assay conditions, including concentration of chemicals and additives (Onoue et al., 2008b; Onoue et al., 2013c; Onoue et al., 2013a) . Although further optimization of assay conditions is needed, the ROS assay employing drug-metabolizing enzymes might become a useful method for hazard identification of metabolite-mediated phototoxicity.
In conclusion, the established photosafety screening on FF with major metabolites 
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